About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

A New Approach towards Anti-Cancer Drugs

by Medindia Content Team on July 25, 2006 at 9:20 PM
Font : A-A+

A New Approach towards Anti-Cancer Drugs

According to the researchers at the Edinburgh University anti cancer drugs should be aimed at preventing MDM2 from destroying p53 molecule. MDM2 is a protein which destroys p53 due to a biochemical imbalance inside the cell.

p53 is the guardian protein and is the tumor suppressor protein. Hence the lead researcher Dr. Kathryn Ball said that anti cancer drugs should be targeted against the MDM2 protein. The study has also pointed out a number of protein fragments which has the ability to bind to the MDM2 protein and inhibit its activity as a cancer promoting catalyst.

Advertisement

This study is being sponsored by the Cancer Research UK. Prof. John Toy, medical director of this organization said that p53 plays a crucial role in conserving stability by preventing genome mutation. Hence he said that if the protein is allowed to perform its function without the interference of the MDM2 protein then this would prevent many types of cancer.

Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

A New Approach towards Anti-Cancer Drugs Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests